The shares of a leading electronics system design and manufacturing player, specializing in providing design, manufacturing, and testing services for electronic systems and solutions are in focus following a Bulk deal and securing a long-term avionics manufacturing contract with Thales.
Price action
With a market capitalization of Rs. 3,282.88 crores on Tuesday, the shares of Cyient DLM Limited were down upto 3 percent making a low of Rs. 408.15 per share compared to its previous closing price of Rs. 421.40 per share.
What Happened
Cyient DLM Limited, a company engaged in providing design, manufacturing, and testing services for electronic systems and solutions, recently experienced a bulk deal, in which its Saravana Securities D Sathyamoorthi Bought 6.01 lakh which consists of 0.75 percent stake at Rs. 420.69 apiece on February 17, resulting in a total value of around Rs. 25.28 Crores.
Along with this, SSPL Securities Private Limited also sold 6.01 lakh shares at Rs 420.67 apiece on February 17, which consists of a 0.75 percent stake in the company, resulting in a total value of around 25.28 crore.
Furthermore, Cyient DLM has secured a long-term avionics manufacturing contract with Thales, announced at Aero India 2025. The company will produce high-reliability Printed Circuit Board Assemblies (PCBAs) for Thales’s next-generation flight avionics systems. This partnership strengthens Cyient DLM’s position as a trusted partner in the global Aerospace and Defense sectors, with these PCBAs set to be used in leading commercial aircraft.
About the company
Cyient DLM Ltd is a leading provider of electronic manufacturing services, It focuses on industries such as aerospace, defense, automotive, and industrial applications, offering services that include hardware design, software development, and integration of complex systems and supporting clients in creating complex, high-performance products.
Revenue Segmentation (Q3 FY25)
Cyient DLM Ltd’s revenue is primarily driven by the Defence sector contributing 46 percent, followed by Aerospace at 22 percent, the Med Tech segment accounts for 18 percent, Industrial makes up 13 percent, and Rail contributes 1 percent to the overall revenue.
Financials
The company’s total revenue rose by 11 percent from Rs. 321 crore to Rs. 357 crore in Q3FY24-25. Meanwhile, Net profit fell from Rs. 18.4 crore to Rs. 15.6 crore during the same period.
Written by Sridhar J
Disclaimer
The views and investment tips expressed by investment experts/broking houses/rating agencies on tradebrains.in are their own, and not that of the website or its management. Investing in equities poses a risk of financial losses. Investors must therefore exercise due caution while investing or trading in stocks. Dailyraven Technologies or the author are not liable for any losses caused as a result of the decision based on this article. Please consult your investment advisor before investing.
